Standard BioTools Inc (NASDAQ: LAB) kicked off on Monday, up 3.72% from the previous trading day, before settling in for the closing price of $2.15. Over the past 52 weeks, LAB has traded in a range of $1.21-$3.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -0.06% over the last five years. While this was happening, its average annual earnings per share was recorded 62.06%. With a float of $360.19 million, this company’s outstanding shares have now reached $372.26 million.
The firm has a total of 539 workers. Let’s measure their productivity. In terms of profitability, gross margin is 48.57%, operating margin of -81.68%, and the pretax margin is -79.83%.
Standard BioTools Inc (LAB) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Standard BioTools Inc is 3.24%, while institutional ownership is 74.18%. The most recent insider transaction that took place on Sep 09 ’24, was worth 91,725. Before that another transaction happened on Aug 27 ’24, when Company’s Director bought 250,000 for $2.19, making the entire transaction worth $546,750. This insider now owns 54,025,821 shares in total.
Standard BioTools Inc (LAB) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.25 earnings per share (EPS), lower than consensus estimate (set at -0.13) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.06% during the next five years compared to 8.72% growth over the previous five years of trading.
Standard BioTools Inc (NASDAQ: LAB) Trading Performance Indicators
Take a look at Standard BioTools Inc’s (LAB) current performance indicators. Last quarter, stock had a quick ratio of 3.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.71, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Standard BioTools Inc (LAB)
Analysing the last 5-days average volume posted by the [Standard BioTools Inc, LAB], we can find that recorded value of 2.46 million was lower than the volume posted last year of 2.47 million. As of the previous 9 days, the stock’s Stochastic %D was 78.83%. Additionally, its Average True Range was 0.13.
During the past 100 days, Standard BioTools Inc’s (LAB) raw stochastic average was set at 85.00%, which indicates a significant decrease from 86.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.32% in the past 14 days, which was lower than the 100.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.93, while its 200-day Moving Average is $2.22. Now, the first resistance to watch is $2.28. This is followed by the second major resistance level at $2.33. The third major resistance level sits at $2.41. If the price goes on to break the first support level at $2.16, it is likely to go to the next support level at $2.08. Should the price break the second support level, the third support level stands at $2.03.
Standard BioTools Inc (NASDAQ: LAB) Key Stats
The company with the Market Capitalisation of 818.72 million has total of 372,259K Shares Outstanding. Its annual sales at the moment are 106,340 K in contrast with the sum of -74,660 K annual income. Company’s last quarter sales were recorded 44,970 K and last quarter income was -26,940 K.
